InnovAge Announces the Resignation of CEO Maureen Hewitt and the Appointment of Patrick Blair as President and CEO
DENVER, Jan. 03, 2022 (GLOBE NEWSWIRE) -- The Board of Directors of InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq:...
News
CAREANIMATIONS Introduces A Proven Solution To Optimally Inform Patients About Their Medication
Personalized animated videos increase understanding and knowledge for patients, with most pronounced changes in lower educated peopleAMSTERDAM, Jan. 03, 2022...
Relay Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to present at the 40th...
Otonomy to Participate in the H.C. Wainwright BioConnect Conference
SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative...
PolyPid Announces Planned CEO Transition
Current EVP & CFO, Dikla Czaczkes Akselbrad, Appointed CEO, Effective July 2022PETAH TIKVA, Israel, Jan. 03, 2022 (GLOBE NEWSWIRE) --...
CinCor Pharma Launches Roadshow for Proposed Initial Public Offering of Common Stock
BOSTON, Jan. 03, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”), a clinical-stage biopharmaceutical company focused on developing its lead...
Genmab to Present at the 40th Annual J.P. Morgan Healthcare Conference
Media ReleaseCOPENHAGEN, Denmark; January 3, 2022Genmab A/S (Nasdaq: GMAB) announced today that its CEO, Jan van de Winkel, Ph.D., will...
Apellis Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement,...
Passage Bio to Present at the 40th Annual J.P. Morgan Healthcare Conference
PHILADELPHIA, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing...
Oncorus to Present at the H.C. Wainwright BioConnect Virtual Conference
CAMBRIDGE, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Oncorus, Inc. (NASDAQ: ONCR), a viral immunotherapies company focused on driving innovation...
Indaptus Therapeutics Announces Appointment of Boyan Litchev, M.D. as Chief Medical Officer
Seasoned Drug Developer Brings More Than Twenty Years of Medical Leadership and Clinical Oncology Experience On Track to Initiate Phase...
C4 Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
WATERTOWN, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company pioneering a...
Applied Therapeutics Provides Regulatory Update on Galactosemia Program
NEW YORK, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline...
Atea Pharmaceuticals to Present at 40th Annual J.P. Morgan Healthcare Conference
BOSTON, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today announced that...
Recro to Present at H.C. Wainwright BioConnect 2022 Conference
SAN DIEGO and GAINESVILLE, Ga., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development...
Altimmune to Present Pemvidutide Clinical Data at Upcoming NASH-TAG Conference January 8, 2022
GAITHERSBURG, Md., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr....
Cerevel to Present at the 40th Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a global company dedicated to unraveling the mysteries...
Clinical Laserthermia Systems AB Promotes Michael Magnani to President of its U.S. Subsidiary, CLS Americas Inc
IRVINE, Calif., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS AB) (Stockholm: CLS B), developer of high...
ObsEva to Present at the H.C. Wainwright BioConnect 2022 Conference
GENEVA, Switzerland January 3, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies...
Immuneering Appoints Rimma Steinhertz, Ph.D., PMP as Vice President, Project and Alliance Management
CAMBRIDGE, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a robust pipeline of...
